Success Stories: NIW Approval Secured for Neuroscientist Advancing Therapies for Neurological Disorders

Client’s Testimonial:

“I would like to thank you for your support during the I-140 process.”

On September 23^rd, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Post-Doctoral Research Scientist in the Field of Neuroscience (Approval Notice).

General Field: Neuroscience

Position at the Time of Case Filing: Post-Doctoral Research Scientist

Country of Origin: Turkey

State of Residence at the Time of Filing: New Jersey

Approval Notice Date: September 23^rd, 2025

Processing Time: 2 months, 28 days (Premium Processing Requested)

Case Summary:

NAILG proudly secured an NIW (National Interest Waiver) approval for a highly accomplished neuroscientist whose work focuses on brain microvascular mechanisms and their role in neurological disorders. His proposed endeavor centers on developing novel therapeutic strategies by identifying how vascular dysfunction contributes to conditions such as dementia, epilepsy, multiple sclerosis, and stroke. This approval reflects both the scientific weight of his research and its alignment with pressing U.S. healthcare priorities.

Addressing a Critical Health Challenge
Neurological disorders are the leading cause of disability worldwide, affecting more than three billion people. In the United States, nearly 240 out of every 100,000 individuals are impacted each year. By targeting the vascular roots of neurological disease, this researcher opens new doors for therapies that go beyond traditional approaches, offering precision medicine strategies to improve patient outcomes and reduce long-term healthcare burdens. Independent experts confirm that his work significantly broadens the field of neuroscience by uncovering overlooked vascular mechanisms driving neurodegeneration.

Recognized Contributions to Science
The petition highlighted an outstanding academic record and evidence of widespread influence:

15 peer-reviewed journal articles (including one first-authored)
10 conference abstracts (two first-authored)
1 preprint expanding the dissemination of his findings
501 citations across publications, including five papers ranked among the most highly cited in Neuroscience & Behavior for their publication years

One expert emphasized:
“Importantly, his research provided the first documented evidence of successful treatment using this targeted delivery system, thus representing a significant advancement in the treatment of disorders previously limited by poor drug access to the central nervous system.”

Positioned for Continued Impact
He is pursuing new investigations into the blood-brain barrier and brain microvascular dysfunction. With robust training, a strong record of high-impact publications, and an innovative research plan, he is exceptionally well-positioned to continue producing breakthroughs that enhance therapeutic options for debilitating neurological diseases.

Approval and Future Outlook
His contributions address both urgent medical needs and long-term challenges in healthcare, promising treatments that will reduce costs, improve equity in access, and strengthen national health resilience. NAILG is honored to have supported this petition and looks forward to the client’s continued leadership in neuroscience and therapeutic innovation.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.